March 17, 2025

Do Congenital Heart Defects Affect Cancer Risk in Newborns and Their Mothers?

A study published in the American Heart Association's journal Circulation explored whether babies born with a congenital heart defects and their mothers may experience an elevated risk of cancer.   

The ASCO Post

March 13, 2025

FDA Chief Counsel Resigns Two Days In

U.S. FDA's chief counsel resigns amidst controversy surrounding her appointment and connections to mifepristone during the Biden administration.

Reuters

March 11, 2025

Doctors Never Truly Vacation, Study Reveals

"Organizations should implement strategies to minimize clinical tasks during PTO."

Conexiant

March 10, 2025

AI Methods Strengthen Real-World Data Reliability

Researchers assessed the impact of AI-driven methods on real-world data reliability, showing improvements in accuracy, completeness, and traceability

Conexiant

March 10, 2025

Infant Gut Microbiota Tied to Childhood Blood Pressure

A 1-unit increase in infant gut microbiota diversity at 1 month was associated with a 1.86 mm Hg lower systolic BP at 6 years—only in children breastfed for at least 6 months.

Conexiant

March 06, 2025

Diabetes Control Declines, Especially Among Young Adults

Researchers find that U.S. diabetes prevalence remained stable from 2013 to 2023, but glycemic control worsened, particularly in young adults, a trend associated with increased cardiovascular risk.

Conexiant

March 06, 2025

Study Finds Reduced Fitness Levels in Pediatric Cardiac Patients

Children with inherited cardiac disease had lower V̇O2max and physical activity levels than healthy peers, with fitness deficits linked to clinical, functional, and behavioral factors, according to a multicenter study.

Conexiant

March 06, 2025

An Estimated 31 Million Americans Borrowed for Medical Bills in 2024

A new West Health-Gallup Survey survey reveals insights into medical debt across all income levels and demographics in the United States.

Conexiant

March 05, 2025

FDA Monthly Round-Up: Key February Updates

February's FDA approvals feature advancements in cardiology, neurology, infectious diseases, and rare disorders, including the first trials for genetically modified pig kidney transplants and novel treatments for Parkinson’s disease and spinal muscular atrophy.

Conexiant